George T. Kannarkat, Dean J. Tuma, Pamela L. Tuma 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Inflammasomes in liver diseases
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 41, Issue 4, Pages (October 2004)
Volume 41, Issue 2, Pages (August 2004)
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 44, Issue 6, Pages (June 2006)
Volume 44, Issue 4, Pages (April 2006)
Loïc Hamon, Philippe Savarin, Patrick A. Curmi, David Pastré 
Volume 103, Issue 5, Pages (September 2012)
Volume 41, Issue 3, Pages (September 2004)
Immigration and viral hepatitis
Volume 41, Issue 3, Pages (September 2004)
Living donor liver transplantation: is the hype over?
Volume 44, Issue 2, Pages (February 2006)
Volume 117, Issue 4, Pages (October 1999)
Volume 44, Issue 3, Pages (March 2006)
Volume 69, Issue 2, Pages (August 2018)
Volume 65, Issue 2, Pages (February 2004)
Volume 42, Issue 6, Pages (June 2005)
Volume 42, Issue 2, Pages (February 2005)
Magnesium regulates tubulin equilibrium through β-CTT.
Hepatitis C core protein – The “core” of immune deception?
Volume 96, Issue 6, Pages e5 (December 2017)
Covalent inhibition of carboxylesterase-2 by sofosbuvir and its effect on the hydrolytic activation of tenofovir disoproxil  Yuanjun Shen, Bingfang Yan 
Cross-Linking of SPINK6 by Transglutaminases Protects from Epidermal Proteases  Jan Fischer, Yulia Koblyakova, Ties Latendorf, Zhihong Wu, Ulf Meyer-Hoffert 
Volume 62, Issue 3, Pages (March 2015)
William M. Bement, Craig A. Mandato, Mary N. Kirsch  Current Biology 
Linda Balabanian, Christopher L. Berger, Adam G. Hendricks 
Acetaminophen (APAP) hepatotoxicity—Isn’t it time for APAP to go away?
Volume 41, Issue 3, Pages (September 2004)
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 13, Issue 2, Pages (May 2006)
Volume 25, Issue 6, Pages e8 (June 2017)
Volume 44, Issue 2, Pages (February 2006)
Economics of chronic hepatitis B and hepatitis C
Transcription Factor MIZ-1 Is Regulated via Microtubule Association
Volume 65, Issue 2, Pages (August 2016)
Volume 17, Issue 6, Pages (March 2007)
Superoxide-induced apoptosis of activated rat hepatic stellate cells
Volume 19, Issue 17, Pages (September 2009)
Yutian Peng, Lois S. Weisman  Developmental Cell 
Volume 103, Issue 11, Pages (December 2012)
All-Trans-Retinoic Acid Induces Interleukin-8 via the Nuclear Factor-κB and p38 Mitogen-Activated Protein Kinase Pathways in Normal Human Keratinocytes 
Volume 42, Issue 2, Pages (February 2005)
The start of a new era in bile physiology
Volume 19, Issue 6, Pages (May 2017)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
R. Dekkers, L. A. W. Vijftigschild, A. M. Vonk, E. Kruisselbrink, K. M
Immigration and viral hepatitis
A Mechanism for Microtubule Depolymerization by KinI Kinesins
Volume 63, Issue 1, Pages (July 2015)
Volume 42, Issue 2, Pages (February 2005)
UA62784 Is a Cytotoxic Inhibitor of Microtubules, not CENP-E
Volume 16, Issue 11, Pages (November 2008)
Pathogenesis of cholestatic hepatitis C
Rapid Secretion of Interleukin-1β by Microvesicle Shedding
RECQL4 is a MAP with a spindle function.
Volume 11, Issue 19, Pages (October 2001)
Synthetic Chromatin Acylation by an Artificial Catalyst System
Volume 103, Issue 11, Pages (December 2012)
Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications.
Volume 64, Issue 3, Pages (March 2016)
Volume 15, Issue 19, Pages (October 2005)
Volume 19, Issue 6, Pages (May 2017)
Cdk1 Negatively Regulates Midzone Localization of the Mitotic Kinesin Mklp2 and the Chromosomal Passenger Complex  Stefan Hümmer, Thomas U. Mayer  Current.
Presentation transcript:

Microtubules are more stable and more highly acetylated in ethanol-treated hepatic cells  George T. Kannarkat, Dean J. Tuma, Pamela L. Tuma  Journal of Hepatology  Volume 44, Issue 5, Pages 963-970 (May 2006) DOI: 10.1016/j.jhep.2005.07.007 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Ethanol impairs microtubule polymerization. WIF-B cells were treated with 50mM ethanol (EtOH) for 72h. In the continued absence or presence of ethanol, 5μM nocodazole was added for 1h at 37°C to depolymerize microtubules. To allow repolymerization, the nocodazole was removed and the cells reincubated at 37°C for the indicated times. Cells were extracted in a microtubule-stabilizing buffer containing 0.15% Triton X-100 for 1min at 37°C. Cells were then lysed in a microtubule stabilizing buffer containing 0.15% Triton X-100. Soluble tubulin was released into the supernatant while polymeric tubulin remained cell-associated. Samples were immunoblotted for α-tubulin (A and B) or acetylated α-tubulin (C). A, The percent of polymeric tubulin at each time point is plotted. B, From the values in A, the percent of total tubulin that repolymerized was calculated. C, The percent of polymeric, acetylated α-tubulin at each time point is plotted. In A and C, values are the average ±SEM from four independent experiments. *P<0.004, **P<0.04. Journal of Hepatology 2006 44, 963-970DOI: (10.1016/j.jhep.2005.07.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Microtubules are shorter and gnarled in ethanol-treated cells. WIF-B cells were treated in the absence or presence of 50mM ethanol (EtOH) for 72h. Phase images (a and b) and α-tubulin labeling are shown (c and d). Asterisks are marking selected BCs. Journal of Hepatology 2006 44, 963-970DOI: (10.1016/j.jhep.2005.07.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Microtubules are more highly acetylated in ethanol-treated cells. A, WIF-B cells were treated in the absence or presence of 50mM ethanol (EtOH) for 72h. Cells were labeled for acetylated α-tubulin. Asterisks are marking selected BCs. B, Cell extracts from control or ethanol-treated WIF-B cells and liver homogenates from control and ethanol pair-fed rats were immunoblotted for α-tubulin and acetylated α-tubulin. Journal of Hepatology 2006 44, 963-970DOI: (10.1016/j.jhep.2005.07.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 4 Microtubules are more stable in ethanol-treated cells. Control (a, c, e and g) or ethanol-treated cells (b, d, f and h) were incubated with 33μM nocodazole for the indicated times and labeled for α-tubulin. Asterisks mark selected BCs. Journal of Hepatology 2006 44, 963-970DOI: (10.1016/j.jhep.2005.07.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 5 Microtubules are more stable in ethanol-treated cells. WIF-B cells were treated with nocodazole for the indicated times then extracted in a microtubule-stabilizing buffer containing 0.15% Triton X-100 for 1min at 37°C. Supernatants (S) containing the released soluble tubulin were collected and cells containing intact polymers (P) were lysed. Samples were immunoblotted for acetylated α-tubulin. The immunoblots shown are representative of three independent experiments. Journal of Hepatology 2006 44, 963-970DOI: (10.1016/j.jhep.2005.07.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 6 Taxol induces more extensive microtubule bundling in ethanol-treated cells. Control (a, c and e) or ethanol-treated cells (b, d, and f) were incubated with 10μM taxol for the indicated times and labeled for α-tubulin. Journal of Hepatology 2006 44, 963-970DOI: (10.1016/j.jhep.2005.07.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 7 Increased microtubule acetylation and stability are time- and dose-dependent. A, WIF-B cells were treated for 0–4 days with 50mM ethanol. B, Cells were treated with the indicated ethanol concentrations for 72h. Samples in A and B were immunoblotted for α-tubulin and acetylated α-tubulin. Acetylated α-tubulin values were normalized to the total α-tubulin present in each sample and their relative levels calculated. The graph in A is representative of four independent experiments. Values in B are the average±SEM from five independent experiments. Journal of Hepatology 2006 44, 963-970DOI: (10.1016/j.jhep.2005.07.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 8 Increased microtubule acetylation and stability are dependent on ethanol metabolism. Microtubule acetylation was monitored by immunoblotting WIF-B cell extracts after the following treatments: A, incubation in the absence or presence of 4-MP (1–3mM) or 50mM ethanol for 72h or B, incubation with 5mM ethanol and increasing cyanamide concentrations (as indicated) for 72h. In A, values are the average±SEM from three independent experiments. In B, a representative immunoblot is shown from three independent experiments. *P<0.03 (4-MP vs. EtOH); **P<0.025 (EtOH vs. EtOH +4-MP). Journal of Hepatology 2006 44, 963-970DOI: (10.1016/j.jhep.2005.07.007) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions